FDA moves to fast-track review of psilocybin and methylone for mental health
- Posted on April 24, 2026
- By CNN
- 0 Views
- 1 min read
FDA moves to fast-track review of psilocybin and methylone for mental health
Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental health treatments in the United States.
